Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells-Reference-Cited by-同舟云学术

Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells

Published:2015-10 Issue: Volume:82 Page:235-242
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Ambrosi Giulia,Ghezzi Cristina,Zangaglia Roberta,Levandis Giovanna,Pacchetti Claudio,Blandini Fabio

Funder

COEN (Centres of Excellence in Neurodegeneration)

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Neurology

Reference55 articles.

1. Chaperone-mediated autophagy markers in Parkinson disease brains;Alvarez-Erviti;Arch. Neurol.,2010

2. Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease;Ambrosi;Biochim. Biophys. Acta,2014

3. Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease;Armentero;Neurobiol. Aging,2011

4. Glucocerebrosidase mutations in primary parkinsonism;Asselta;Parkinsonism Relat Disord.,2014

5. GSK-3 and lysosomes meet in Alzheimer's disease;Avrahami;Commun. Integr. Biol.,2013

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease;Translational Neurodegeneration;2024-09-12

2. Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies;Cellular and Molecular Life Sciences;2024-09-03

3. Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease;Neurochemistry International;2024-09

4. Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery;Philosophical Transactions of the Royal Society B: Biological Sciences;2024-02-19

5. Exploring the efficacy and safety of Ambroxol in Gaucher disease: an overview of clinical studies;Frontiers in Pharmacology;2024-02-13